Next Science Limited (NXS.AX)

AUD 0.1

(-1.0%)

Revenue Summary of Next Science Limited

  • Next Science Limited's latest annual revenue in 2023 was 22.17 Million USD , up 97.77% from previous year.
  • Next Science Limited's latest quarterly revenue in 2024 Q2 was 16.84 Million AUD , down -10.77% from previous quarter.
  • Next Science Limited reported a annual revenue of 16.89 Million USD in annual revenue 2022, up 41.73% from previous year.
  • Next Science Limited reported a annual revenue of 11.92 Million AUD in annual revenue 2021, up 138.5% from previous year.
  • Next Science Limited reported a quarterly revenue of 33.41 Million USD for 2023 FY, up 97.77% from previous quarter.
  • Next Science Limited reported a quarterly revenue of 14.96 Million AUD for 2023 Q2, up 59.12% from previous quarter.

Annual Revenue Chart of Next Science Limited (2023 - 2016)

Historical Annual Revenue of Next Science Limited (2023 - 2016)

Year Revenue Revenue Growth
2023 22.17 Million USD 97.77%
2022 16.89 Million USD 41.73%
2021 11.92 Million AUD 138.5%
2020 4.99 Million AUD -14.46%
2019 5.84 Million AUD 56.51%
2018 3.73 Million AUD 0.0%
2017 - AUD -100.0%
2016 118.83 Thousand AUD 0.0%

Peer Revenue Comparison of Next Science Limited

Name Revenue Revenue Difference
Althea Group Holdings Limited 29.4 Million AUD 24.563%
Cann Group Limited 15.37 Million AUD -44.275%
ECS Botanics Holdings Ltd 20.03 Million AUD -10.729%
Ecofibre Limited 27.98 Million AUD 20.743%
Elixinol Wellness Limited 8.26 Million AUD -168.223%
Hygrovest Limited 260 Thousand AUD -8430.51%
IDT Australia Limited 13.22 Million AUD -67.695%
Invion Limited 3.69 Million AUD -500.373%
Little Green Pharma Ltd 19.56 Million AUD -13.346%
Live Verdure Ltd 1.93 Million AUD -1045.618%
Medical Developments International Limited 33.14 Million AUD 33.092%
Vitura Health Limited 123.87 Million AUD 82.095%
Vita Life Sciences Limited 74.16 Million AUD 70.093%